These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14148183)
1. [BASIC TRENDS IN THE SYNTHESIS OF HYPOTENSIVE AGENTS. II]. RUBTSOV MV Med Prom SSSR; 1963 Dec; 17():16-24. PubMed ID: 14148183 [No Abstract] [Full Text] [Related]
2. [MODIFICATIONS OF EXCITABILITY OF THE VASOMOTOR CENTERS BY SUBSTANCES INTERFERING PERIPHERALLY WITH THE EFFECTS OF THE SYMPATHETIC NERVOUS SYSTEM]. SCHMITT H; SCHMITT H Arch Int Pharmacodyn Ther; 1964 Aug; 150():322-35. PubMed ID: 14205399 [No Abstract] [Full Text] [Related]
3. THE EFFECTS OF RESERPINE,GUANETHIDINE AND OTHER AUTONOMIC DRUGS ON FREE FATTY ACID MOBILIZATION INDUCED BY PHENTOLAMINE. BOSHART CR; WILL L; PIRRE A; RINGLER I J Pharmacol Exp Ther; 1965 Jul; 149():57-64. PubMed ID: 14334292 [No Abstract] [Full Text] [Related]
4. [PHARMACOLOGY OF SOME NEW HYPOTENSIVE DRUGS]. KRUSHKOV I Suvr Med (Sofiia); 1964; 15():46-54. PubMed ID: 14247058 [No Abstract] [Full Text] [Related]
5. On the mechanism of hypotensive effects of MAO inhibitors. GESSA GL; CUENCA E; COSTA E Ann N Y Acad Sci; 1963 Jul; 107():935-44. PubMed ID: 13947412 [No Abstract] [Full Text] [Related]
7. EFFECTS OF PREVIOUS AND CONCOMITANT DRUG THERAPY ON SURGERY AND ANESTHESIA. CLARK RB; MAIER ES GP; 1964 Jan; 29():106-11. PubMed ID: 14104210 [No Abstract] [Full Text] [Related]
8. THE CHOICE OF HYPOTENSIVE AGENTS. PALMER KN Practitioner; 1964 Jul; 193():43-9. PubMed ID: 14194585 [No Abstract] [Full Text] [Related]
9. HAZARDS OF ANTIHYPERTENSIVE THERAPY. PATON DM S Afr Med J; 1964 Jan; 38():31-4. PubMed ID: 14105784 [No Abstract] [Full Text] [Related]
10. INTERRELATIONSHIPS BETWEEN AMPHETAMINE AND HARMALA ALKALOIDS. SCHMITT H; SCHMITT H Nature; 1964 Aug; 203():877-8. PubMed ID: 14204082 [No Abstract] [Full Text] [Related]
11. Some pharmacological actions of bretylium and guanethidine. VERNIKOS-DANELLIS J; ZAIMIS E Lancet; 1960 Oct; 2(7154):787-8. PubMed ID: 13780968 [No Abstract] [Full Text] [Related]
13. The inhibition of monoamine oxidase by benzyl and phenethylguanidines related to bretylium and guanethidine. KUNTZMAN R; JACOBSON MM Ann N Y Acad Sci; 1963 Jul; 107():945-50. PubMed ID: 13927386 [No Abstract] [Full Text] [Related]
14. Selective potentiation of sympathomimetic amines by reserpine. syrosingopine and 2,6-xylylcholine ether bromide (TM-10) in the dog. ROSS CA; WENGER HC; LUDDEN CT; STONE CA Arch Int Pharmacodyn Ther; 1963 Mar; 142():141-51. PubMed ID: 13975072 [No Abstract] [Full Text] [Related]
15. Bretylium and guanethidine: two new drugs producing specific blockade of the sympathetic nervous system. FREIS ED Heart Bull; 1960; 9():88-9. PubMed ID: 13824829 [No Abstract] [Full Text] [Related]
16. Inhibition of adrenergic function in the treatment of hypertension. Frohlich ED Arch Intern Med; 1974 Jun; 133(6):1033-48. PubMed ID: 4151442 [No Abstract] [Full Text] [Related]
18. Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine. GILLESPIE L Ann N Y Acad Sci; 1960 Oct; 88():1011-20. PubMed ID: 13705343 [No Abstract] [Full Text] [Related]
19. [Central effects of some adrenergic blocking and-or sympatholytic substances. II. Action on spontaneous motility and potentialization of pentobarbital]. Boissier JR; Simon P; Giudicelli JF Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):312-9. PubMed ID: 6064561 [No Abstract] [Full Text] [Related]
20. CURRENT TREATMENT OF HYPERTENSION WITH DRUGS. WOLF RL; MENDLOWITZ M; NAFTCHI NE; GITLOW SE Am Heart J; 1963 Sep; 66():414-28. PubMed ID: 14056794 [No Abstract] [Full Text] [Related] [Next] [New Search]